Displaying 321 - 330 of 632
Nino
Updated:
Nino Maclang, of Vancouver, British Columbia, was diagnosed with stage 4 Hodgkin lymphoma (HL), and is now in remission thanks in larger part to his wife Lisa.
Image
Diffuse Large B-Cell Lymphoma (DLBCL)
Updated:
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). DLBCL is fast-growing (aggressive) but treatable. It most often appears in older adults but can appear at any age.
Lymphoma
Image
Cutaneous T-cell Lymphoma (CTCL)
Updated:
Cutaneous T-cell lymphoma (CTCL) is a slow-growing (indolent) subtype of non-Hodgkin lymphoma (NHL). CTCL is rare, representing 4% of NHL cases. It starts in white blood cells (lymphocytes) that reside in the skin, called T-cells.
Lymphoma
Image
Understanding mantle cell lymphoma (MCL)
Updated:
Mantle cell lymphoma (MCL) is an aggressive subtype of non-Hodgkin lymphoma. It is a blood cancer of the B-lymphocytes (type of white blood cell that fights infections) found in the bone marrow. Learn more about MCL in this animated video.
Lymphoma
Image
Myelodysplastic syndromes (MDS)
Updated:
Myelodysplastic syndromes are a group of cancers of the blood and bone marrow. With an MDS, your bone marrow – the soft, spongy material inside your bones – does not produce enough healthy blood cells.
Myelodysplastic syndromes
Image
Acute Myeloid Leukemia (AML)
Updated:
AML is one of four main types of leukemia. It progresses quickly if untreated. It features cancerous blood cells, often called “blasts.” AML typically affects adults over the age of 65 and is slightly more common in men.
Leukemia
Image
Angioimmunoblastic T-cell Lymphoma (AITL)
Updated:
AITL is a rare, fast-growing (aggressive) T-cell subtype of non-Hodgkin lymphoma (NHL) and a common subtype of peripheral T-cell lymphoma (PTCL). AITL typically affects adults over 50.
Lymphoma
Blood cancer ambassador featured in Canadian Blood Services video
Updated:
Adam, of Toronto, is a blood and stem cell recipient who was diagnosed with leukemia two days after finding out he was going to become a father.
The role of pharmacists in supporting access to novel cancer treatments
Updated:
The Leukemia & Lymphoma Society of Canada were honoured to be invited to speak at the Canadian Association of Pharmacy in Oncology (CAPhO) in Moncton, New Brunswick this month.
Canadians are ‘dying to be a priority’ in accessing cancer treatments: Open letter to the Premiers
Updated:
LLSC is at the frontlines in advocating for more timely, equitable cancer treatment access, and this week this issue was elevated publicly in light of a meeting of Canada’s premiers (a group called Council of Federation).